Edition:
United Kingdom

People: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

123.13USD
9:00pm BST
Change (% chg)

$-0.76 (-0.61%)
Prev Close
$123.89
Open
$124.36
Day's High
$124.65
Day's Low
$122.50
Volume
99,485
Avg. Vol
154,382
52-wk High
$152.55
52-wk Low
$100.64

Edgemond, James 

Mr. James C. Edgemond serves as Chief Financial Officer, Treasurer of the Company. He joined United Therapeutics in January 2013 as Treasurer and Vice President, Strategic Financial Planning. Mr. Edgemond was promoted to Chief Financial Officer and Treasurer in March 2015. Prior to joining United Therapeutics, he was Vice President, Corporate Controller and Treasurer of Clark Construction Group from November 2008 through January 2013. He also served in a variety of roles at The Corporate Executive Board Company from 1998 to 2008, including most recently as Executive Director, Finance from 2005 to 2008. He began his career as a public accountant at KPMG Peat Marwick LLP, where he served in a variety of roles from 1990 through 1998, including most recently as a Senior Manager.

Basic Compensation

Total Annual Compensation, USD 620,833
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 7,455,060
Fiscal Year Total, USD 8,075,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Martine Rothblatt

35,535,000

Michael Benkowitz

10,818,700

Christopher Patusky

570,953

James Edgemond

8,075,900

Paul Mahon

12,215,200

Raymond Dwek

488,652
As Of  31 Dec 2017